Zobrazeno 1 - 10
of 134
pro vyhledávání: '"Howard M. Katzenstein"'
Autor:
Allison F. O’Neill, Angela Trobaugh-Lotrario, James I. Geller, Eiso Hiyama, Kenichiro Watanabe, Isabelle Aerts, Brice Fresneau, Fabienne Toutain, Michael J. Sullivan, Howard M. Katzenstein, Bruce Morland, Sophie Branchereau, József Zsiros, Rudolf Maibach, Marc Ansari
Publikováno v:
EClinicalMedicine, Vol 69, Iss , Pp 102446- (2024)
Summary: Liver tumors account for approximately 2% of all pediatric malignancies. Children with advanced stages of hepatoblastoma (HB) are cured only 50–70% of the time while children with advanced hepatocellular carcinoma (HCC) have a
Externí odkaz:
https://doaj.org/article/42c5ffa719204affb45100312339861c
Autor:
Nathan D. Seligson, Richard D. Maradiaga, Colin M. Stets, Howard M. Katzenstein, Sherri Z. Millis, Alan Rogers, John L. Hays, James L. Chen
Publikováno v:
npj Precision Oncology, Vol 5, Iss 1, Pp 1-11 (2021)
Abstract Sarcomas harboring EWSR1-NFATc2 fusions have historically been categorized and treated as Ewing sarcoma. Emerging evidence suggests unique molecular characteristics and chemotherapy sensitivities in EWSR1-NFATc2 fusion positive sarcomas. Com
Externí odkaz:
https://doaj.org/article/7d31feddde0942de830ce709ec748972
Autor:
Thomas Cash, Hong Yin, Courtney McCracken, Zhi Geng, Steven G. DuBois, Bahig M. Shehata, Thomas A. Olson, Howard M. Katzenstein, Cynthia Wetmore
Publikováno v:
Sarcoma, Vol 2017 (2017)
Background. Ezrin is a membrane-cytoskeleton linker protein that has been associated with metastasis and poor outcomes in osteosarcoma and high-grade soft tissue sarcomas. The prognostic value of ezrin expression in Ewing sarcoma is unknown. Methods.
Externí odkaz:
https://doaj.org/article/d059f513979348e9b8eb959389b513c1
Autor:
Nathan C. Rowland, Jennifer Andrews, Daxa Patel, David V. LaBorde, Adam Nowlan, Bradley George, Claire Mazewski, Andrew Reisner, Howard M. Katzenstein
Publikováno v:
Case Reports in Neurological Medicine, Vol 2012 (2012)
Intracranial metastasis of neuroblastoma (IMN) is associated with poor survival. No curative therapy for the treatment of IMN currently exists. Unfractionated radiotherapy may be beneficial in the treatment of IMN given the known radiosensitivity of
Externí odkaz:
https://doaj.org/article/7302e2a2c0ea4c5ba3bcb7a68d664139
Autor:
Sanjeev A Vasudevan, Rebecka L Meyers, Milton J Finegold, Dolores López-Terrada, Sarangarajan Ranganathan, Stephen P Dunn, Max R Langham, Eugene D McGahren, Greg M Tiao, Christopher B Weldon, Marcio H Malogolowkin, Mark D Krailo, Jin Piao, Jessica Randazzo, Alexander J Towbin, M. BethMcCarville, Allison F O'Neill, Wayne L Furman, Carlos Rodriguez-Galindo, Howard M Katzenstein
Publikováno v:
Journal of Pediatric Surgery. 57:251-256
Hepatoblastoma (HB) requires surgical resection for cure, but only 20-30% of patients have resectable disease at diagnosis. Patients who undergo partial hepatectomy at diagnosis have historically received 4-6 cycles of adjuvant chemotherapy; however,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f50dbbe16ee8366ab8232e88f11b628
https://doi.org/10.1016/j.jpedsurg.2022.05.022
https://doi.org/10.1016/j.jpedsurg.2022.05.022
Autor:
Patrick A. Thompson, Marcio H. Malogolowkin, Wayne L. Furman, Jin Piao, Mark D. Krailo, Nadia Chung, Lindsay Brock, Alexander J. Towbin, Elizabeth B. McCarville, Milton J. Finegold, Sarangarajan Ranganathan, Stephen P. Dunn, Max R. Langham, Eugene D. McGahren, Gregory M. Tiao, Christopher B. Weldon, Allison F. O'Neill, Carlos Rodriguez‐Galindo, Rebecka L. Meyers, Howard M. Katzenstein
Publikováno v:
Pediatric Blood & Cancer. 70
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4947da926f304a072f2e9c49b2e1f60a
https://doi.org/10.1002/pbc.30365
https://doi.org/10.1002/pbc.30365
Autor:
Eugene D. McGahren, M. Beth McCarville, Howard M. Katzenstein, Carlos Rodriguez-Galindo, Rebecka L. Meyers, Jin Piao, Wayne L. Furman, Nadia Chung, Christopher B. Weldon, Mark Krailo, Alexander J. Towbin, Patrick A. Thompson, Allison F. O'Neill, Sarangarajan Ranganathan, Stephen P. Dunn, Marcio H. Malogolowkin, Milton J. Finegold, Jessica Randazzo, Angela D. Trobaugh-Lotrario, Max R. Langham, Gregory M. Tiao
Publikováno v:
Cancer
Background The Children's Oncology Group (COG) adopted cisplatin, 5-flourouracil, and vincristine (C5V) as standard therapy after the INT-0098 legacy study showed statistically equivalent survival but less toxicity in comparison with cisplatin and do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efada3819455da3e3a6d36c2bd1c7ec4
https://doi.org/10.1002/cncr.34014
https://doi.org/10.1002/cncr.34014
Autor:
Colin M Stets, Richard D Maradiaga, Alan Rogers, Sherri Z. Millis, John L. Hays, Howard M. Katzenstein, Nathan D. Seligson, James L. Chen
Publikováno v:
npj Precision Oncology, Vol 5, Iss 1, Pp 1-11 (2021)
NPJ Precision Oncology
NPJ Precision Oncology
Sarcomas harboring EWSR1-NFATc2 fusions have historically been categorized and treated as Ewing sarcoma. Emerging evidence suggests unique molecular characteristics and chemotherapy sensitivities in EWSR1-NFATc2 fusion positive sarcomas. Comprehensiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2d6b6d5aafb733644c368a924284e1c
https://doaj.org/article/7d31feddde0942de830ce709ec748972
https://doaj.org/article/7d31feddde0942de830ce709ec748972
Publikováno v:
Clinics in Perinatology. 48:83-99
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::633c5fe3a856b43b0c2718b7509bdf68
https://doi.org/10.1016/j.clp.2020.11.005
https://doi.org/10.1016/j.clp.2020.11.005
Autor:
Rajen Mody, Barry L. Shulkin, Mildred Felder, Paul M. Sondel, Howard M. Katzenstein, Wendy B. London, Shahab Asgharzadeh, Alice L. Yu, Julia Glade-Bender, Rochelle Bagatell, Marguerite T. Parisi, Arlene Naranjo, Jennifer Birstler, Fan F Zhang, Mitchell B. Diccianni, Jacquelyn A. Hank, Julie R. Park, Sabah-E-Noor Servaes, John M. Maris
Publikováno v:
J Clin Oncol
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 38, iss 19
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 38, iss 19
PURPOSE The combination of irinotecan, temozolomide, dintuximab, and granulocyte-macrophage colony-stimulating factor (I/T/DIN/GM-CSF) demonstrated activity in patients with relapsed/refractory neuroblastoma in the randomized Children’s Oncology Gr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c5fc7862ed09510979d031932389b42
https://doi.org/10.1200/jco.20.00203
https://doi.org/10.1200/jco.20.00203